NovaBay Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • NovaBay Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $117K, a 3.54% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $552K, a 24.9% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $543K, a 0.56% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $540K, a 13.7% increase from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $475K, a 48.8% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $543K +$3K +0.56% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $540K +$65K +13.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $475K -$452K -48.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $927K -$358K -27.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $1.29M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.